Nalin MedTech — Korean Medical Innovation
Advanced Korean medical technology for European clinics & pharmacies
We bring vetted Korean diagnostic and monitoring devices — AI chest-CT analysis and needle-free laser glucose monitoring — to European healthcare, with full compliance support and English-speaking partnership.
Korean medical technology distribution for Europe
A trusted Korea-to-Europe bridge for medical innovation
Nalin MedTech extends our established Korean supply network into advanced healthcare technology. We partner with leading Korean manufacturers to bring diagnostic and monitoring devices to European clinics, pharmacies and health-screening centres — backed by compliance support and responsive, English-speaking service.
Our medical technology portfolio
ORTIV — Painless laser blood-glucose monitoring
A handheld device combining needle-free laser blood sampling with glucose measurement — ideal for pharmacy chains and chronic-care networks. US FDA 510(k)-cleared lancing instrument; by MVITRO (Korea).
HEXA — AI chest-CT analysis for 6 organs
AI software that screens lungs, heart, liver, thyroid, spine and breast from a single chest CT and auto-generates a structured report — easing radiologist workload and unlocking new screening revenue. By Xcube (Korea).
Frequently asked questions
What is Nalin MedTech?
The medical-technology division of Nalin Korean Beauty Exports, distributing advanced Korean diagnostic and monitoring devices — the ORTIV laser blood-glucose monitor and the HEXA AI chest-CT analysis solution — to clinics, pharmacies and distributors across Europe.
What is HEXA?
An AI-based chest-CT analysis solution by Xcube (Republic of Korea). From one chest CT it screens six organs — lungs, heart, liver, thyroid, spine and breast — detecting calcifications and lesions and producing a structured report for physician review.
What is ORTIV?
A handheld blood-glucose monitor by MVITRO (Republic of Korea) that combines needle-free laser blood sampling with glucose measurement — removing the pain, fear and disposable-needle waste of finger-prick testing.
Are these devices available for sale in the EU?
CE marking under EU MDR/IVDR is in progress. These pages are professional information for prospective distribution partners and do not constitute an offer for sale within the EU/EEA. Contact us to discuss European distribution partnerships.
EU availability & regulatory compliance
Brought to the European market the right way
Nalin MedTech prepares every device for the European market in full accordance with EU regulation. The information on these pages is provided to professional distribution partners exploring future supply, and does not constitute an offer for sale within the EU/EEA.
- Medical devices are regulated under the EU Medical Device Regulation (MDR) 2017/745.
- In-vitro diagnostics (e.g. blood-glucose monitoring) are regulated under the EU IVD Regulation (IVDR) 2017/746.
- CE marking is in progress. Until a device carries CE marking it cannot be placed on the EU/EEA market.
- For each manufacturer we work toward CE conformity, appointment of an EU Authorised Representative, and EUDAMED registration.
- All partnership inquiries are handled in line with the GDPR.
Any FDA or Korean (MFDS) clearances referenced apply only to those jurisdictions.
Bring Korean medical innovation to your market
Distributors, clinics and pharmacy networks — request a briefing and documentation pack.